185 related articles for article (PubMed ID: 10070314)
21. Overexpression of BRCA2 gene in sporadic breast tumours.
Bièche I; Noguès C; Lidereau R
Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
[TBL] [Abstract][Full Text] [Related]
22. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
Gonzalez R; Silva JM; Dominguez G; Garcia JM; Martinez G; Vargas J; Provencio M; España P; Bonilla F
Br J Cancer; 1999 Oct; 81(3):503-9. PubMed ID: 10507777
[TBL] [Abstract][Full Text] [Related]
23. Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
Gorgoulis VG; Kotsinas A; Zacharatos P; Mariatos G; Liloglou T; Tsoli E; Kokotas S; Fassoulas C; Field JK; Kittas C
Cancer; 2000 Nov; 89(9):1933-45. PubMed ID: 11064350
[TBL] [Abstract][Full Text] [Related]
24. Loss of heterozygosity in the RAD51 and BRCA2 regions in breast cancer.
Nowacka-Zawisza M; Bryś M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Cancer Detect Prev; 2008; 32(2):144-8. PubMed ID: 18632222
[TBL] [Abstract][Full Text] [Related]
25. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.
Rio PG; Pernin D; Bay JO; Albuisson E; Kwiatkowski F; De Latour M; Bernard-Gallon DJ; Bignon YJ
Int J Oncol; 1998 Oct; 13(4):849-53. PubMed ID: 9735416
[TBL] [Abstract][Full Text] [Related]
26. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours.
Pearce SH; Trump D; Wooding C; Sheppard MN; Clayton RN; Thakker RV
Clin Endocrinol (Oxf); 1996 Aug; 45(2):195-200. PubMed ID: 8881452
[TBL] [Abstract][Full Text] [Related]
27. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
[TBL] [Abstract][Full Text] [Related]
28. Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues.
Mutirangura A; Charuruks N; Shuangshoti S; Sakdikul S; Chatsantikul R; Pornthanakasem W; Sriuranpong V; Supiyaphun P; Voravud N
Int J Cancer; 1999 Oct; 83(2):210-4. PubMed ID: 10471529
[TBL] [Abstract][Full Text] [Related]
29. Allelic imbalance on chromosomes 13 and 17 and mutation analysis of BRCA1 and BRCA2 genes in monozygotic twins concordant for breast cancer.
Försti A; Luo L; Vorechovsky I; Söderberg M; Lichtenstein P; Hemminki K
Carcinogenesis; 2001 Jan; 22(1):27-33. PubMed ID: 11159737
[TBL] [Abstract][Full Text] [Related]
30. Allelic loss on chromosome bands 13q11-q13 in esophageal squamous cell carcinoma.
Li G; Hu N; Goldstein AM; Tang ZZ; Roth MJ; Wang QH; Dawsey SM; Han XY; Ding T; Huang J; Giffen C; Taylor PR; Emmert-Buck MR
Genes Chromosomes Cancer; 2001 Aug; 31(4):390-7. PubMed ID: 11433530
[TBL] [Abstract][Full Text] [Related]
31. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.
Collins N; McManus R; Wooster R; Mangion J; Seal S; Lakhani SR; Ormiston W; Daly PA; Ford D; Easton DF
Oncogene; 1995 Apr; 10(8):1673-5. PubMed ID: 7731724
[TBL] [Abstract][Full Text] [Related]
32. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
[TBL] [Abstract][Full Text] [Related]
33. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.
Hamann U; Herbold C; Costa S; Solomayer EF; Kaufmann M; Bastert G; Ulmer HU; Frenzel H; Komitowski D
Cancer Res; 1996 May; 56(9):1988-90. PubMed ID: 8616837
[TBL] [Abstract][Full Text] [Related]
34. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
[TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer.
Nowacka-Zawisza M; Forma E; Walczak M; Różański W; Bryś M; Krajewska WM
Med Oncol; 2015 Nov; 32(11):246. PubMed ID: 26433958
[TBL] [Abstract][Full Text] [Related]
36. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer.
Dong JT; Boyd JC; Frierson HF
Prostate; 2001 Nov; 49(3):166-71. PubMed ID: 11746261
[TBL] [Abstract][Full Text] [Related]
37. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer.
Hanby AM; Kelsell DP; Potts HW; Gillett CE; Bishop DT; Spurr NK; Barnes DM
Int J Cancer; 2000 Oct; 88(2):204-8. PubMed ID: 11004669
[TBL] [Abstract][Full Text] [Related]
38. Somatic mutations in the BRCA2 gene and high frequency of allelic loss of BRCA2 in sporadic male breast cancer.
Kwiatkowska E; Teresiak M; Breborowicz D; Mackiewicz A
Int J Cancer; 2002 Apr; 98(6):943-5. PubMed ID: 11948477
[TBL] [Abstract][Full Text] [Related]
39. Loss of BRCA2 correlates with reduced long-term survival of sporadic breast cancer patients.
Hampl JA; Hampl M; Reiss G; Koch R; Saeger HD; Schackert HK
Anticancer Res; 2004; 24(1):281-90. PubMed ID: 15015609
[TBL] [Abstract][Full Text] [Related]
40. Loss of heterozygosity in bilateral breast cancer.
Kollias J; Man S; Marafie M; Carpenter K; Pinder S; Ellis IO; Blamey RW; Cross G; Brook JD
Breast Cancer Res Treat; 2000 Dec; 64(3):241-51. PubMed ID: 11200774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
